Cardiome Pharma Corp (COM) Insider Jennifer Archibald Sells 17,164 Shares
Cardiome Pharma Corp (TSE:COM) (NASDAQ:CRME) insider Jennifer Archibald sold 17,164 shares of the stock in a transaction on Tuesday, October 10th. The shares were sold at an average price of C$2.51, for a total value of C$43,081.64.
Jennifer Archibald also recently made the following trade(s):
- On Wednesday, September 27th, Jennifer Archibald sold 300 shares of Cardiome Pharma Corp stock. The shares were sold at an average price of C$2.56, for a total value of C$768.00.
Shares of Cardiome Pharma Corp (TSE:COM) traded down 1.60% during mid-day trading on Monday, reaching $2.46. The company’s stock had a trading volume of 10,700 shares. The stock’s market cap is $83.15 million. The stock has a 50 day moving average of $2.75 and a 200-day moving average of $4.44. Cardiome Pharma Corp has a one year low of $2.45 and a one year high of $6.06.
COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/cardiome-pharma-corp-com-insider-jennifer-archibald-sells-17164-shares/1635052.html.
Cardiome Pharma Corp Company Profile
Cardiome Pharma Corp. (Cardiome) is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies for heart disease. The Company’s segments are Europe and Rest of World. Cardiome has two marketed, in-hospital, cardiology products, which include BRINAVESS (vernakalant IV), approved in Europe and other territories for the conversion of onset atrial fibrillation (AF) to sinus rhythm in adults, and AGGRASTAT (tirofiban hydrochloride (HCl)), indicated for use in patients with acute coronary syndrome.
Receive News & Ratings for Cardiome Pharma Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiome Pharma Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.